Search Results Search Sort by RelevanceMost Recent In the Literature Oct 2002 Should Clinician-Researchers Disclose Financial Incentives to Patients? Jeremy Spevick Virtual Mentor. 2002;4(10):299-301. doi: 10.1001/virtualmentor.2002.4.10.jdsc1-0210. Viewpoint Dec 2002 The Twelve Days of Christmas Audiey Kao, MD, PhD Virtual Mentor. 2002;4(12):370-371. doi: 10.1001/virtualmentor.2002.4.12.dykn1-0212. In the Literature Apr 2005 Self-Regulation and the Relationship of Physicians with the Pharmaceutical Industry Justin M. Thomas Virtual Mentor. 2005;7(4):288-293. doi: 10.1001/virtualmentor.2005.7.4.jdsc1-0504. Case and Commentary Jun 2006 Hidden Costs of Free Samples Richard Adair, MD Virtual Mentor. 2006;8(6):367-371. doi: 10.1001/virtualmentor.2006.8.6.ccas2-0606. Case and Commentary Jun 2006 The Gift-Giving Influence Frederick S. Sierles, MD Virtual Mentor. 2006;8(6):372-376. doi: 10.1001/virtualmentor.2006.8.6.ccas3-0606. Case and Commentary Mar 2006 The Pitfalls of Drug Company Sample Use Robert Goodman, MD Virtual Mentor. 2006;8(3):138-141. doi: 10.1001/virtualmentor.2006.8.3.ccas3-0603. Viewpoint Jun 2006 "This May Sting a Bit": Cutting CME's Ties to Pharma Adriane Fugh-Berman, MD and Sharon Batt, MA Virtual Mentor. 2006;8(6):412-415. doi: 10.1001/virtualmentor.2006.8.6.oped1-0606. Viewpoint Jun 2006 Independence in Continuing Medical Education Murray Kopelow, MD, MSC, FRCPC Virtual Mentor. 2006;8(6):416-419. doi: 10.1001/virtualmentor.2006.8.6.oped2-0606. Medical Education Aug 2006 Pharmaceutical Support of Dermatology Residency Electives: Slippery Slope or Synergy? Alfred T. Lane, MD Virtual Mentor. 2006;8(8):509-511. doi: 10.1001/virtualmentor.2006.8.8.medu1-0608. Case and Commentary Aug 2005 Finding the (Right) Time: Physician-to-Drug Rep Communication Michael E. Roloff, PhD and Rachel Malis, MA Virtual Mentor. 2005;7(8):554-558. doi: 10.1001/virtualmentor.2005.7.8.ccas5-0508. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
In the Literature Oct 2002 Should Clinician-Researchers Disclose Financial Incentives to Patients? Jeremy Spevick Virtual Mentor. 2002;4(10):299-301. doi: 10.1001/virtualmentor.2002.4.10.jdsc1-0210.
Viewpoint Dec 2002 The Twelve Days of Christmas Audiey Kao, MD, PhD Virtual Mentor. 2002;4(12):370-371. doi: 10.1001/virtualmentor.2002.4.12.dykn1-0212.
In the Literature Apr 2005 Self-Regulation and the Relationship of Physicians with the Pharmaceutical Industry Justin M. Thomas Virtual Mentor. 2005;7(4):288-293. doi: 10.1001/virtualmentor.2005.7.4.jdsc1-0504.
Case and Commentary Jun 2006 Hidden Costs of Free Samples Richard Adair, MD Virtual Mentor. 2006;8(6):367-371. doi: 10.1001/virtualmentor.2006.8.6.ccas2-0606.
Case and Commentary Jun 2006 The Gift-Giving Influence Frederick S. Sierles, MD Virtual Mentor. 2006;8(6):372-376. doi: 10.1001/virtualmentor.2006.8.6.ccas3-0606.
Case and Commentary Mar 2006 The Pitfalls of Drug Company Sample Use Robert Goodman, MD Virtual Mentor. 2006;8(3):138-141. doi: 10.1001/virtualmentor.2006.8.3.ccas3-0603.
Viewpoint Jun 2006 "This May Sting a Bit": Cutting CME's Ties to Pharma Adriane Fugh-Berman, MD and Sharon Batt, MA Virtual Mentor. 2006;8(6):412-415. doi: 10.1001/virtualmentor.2006.8.6.oped1-0606.
Viewpoint Jun 2006 Independence in Continuing Medical Education Murray Kopelow, MD, MSC, FRCPC Virtual Mentor. 2006;8(6):416-419. doi: 10.1001/virtualmentor.2006.8.6.oped2-0606.
Medical Education Aug 2006 Pharmaceutical Support of Dermatology Residency Electives: Slippery Slope or Synergy? Alfred T. Lane, MD Virtual Mentor. 2006;8(8):509-511. doi: 10.1001/virtualmentor.2006.8.8.medu1-0608.
Case and Commentary Aug 2005 Finding the (Right) Time: Physician-to-Drug Rep Communication Michael E. Roloff, PhD and Rachel Malis, MA Virtual Mentor. 2005;7(8):554-558. doi: 10.1001/virtualmentor.2005.7.8.ccas5-0508.